Webinar: Standardization and Large-scale Manufacturing of Plasmids for Viral Vector Production

Success in gene and cell therapy has increased demand for plasmid DNA used to produce viral vectors, both in quantities for commercial products as well as the breadth of different vectors for the expanding number of programs in development. This webinar, done in conjunction with Phacilitate: Exchange, discusses this topic.